SEC recommends Phase-1 clinical trials of RIL's Covid vaccine candidate

The trials will be done at 10 sites in India, including centres in Tamil Nadu, Andhra Pradesh, Maharashtra and Delhi

from Latest News https://ift.tt/3jletX9
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share